Operating Segments (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Schedule of operating segments

	Three Months Ended March 31,
	2020			2019
Revenues
Public Health Solutions	$	908,807		$	680,353
Specialized BioTherapeutics		15,745			464,435
Total	$	924,552		$	1,144,788
Loss from Operations
Public Health Solutions	$	(158,502	)	$	(9,011	)
Specialized BioTherapeutics		(7,357,853	)		(1,335,557	)
Corporate		(957,437	)		(955,495	)
Total	$	(8,473,792	)	$	(2,300,063	)
Amortization and Depreciation Expense
Public Health Solutions	$	7,303		$	4,402
Specialized BioTherapeutics		3,070			4,677
Corporate		7,273			2,841
Total	$	17,646		$	11,920
Other Income, Net
Specialized BioTherapeutics	$	33,618		$	5,007
Corporate		21,947			44,753
Total	$	55,565		$	49,760
Share-Based Compensation
Public Health Solutions	$	9,465		$	5,196
Specialized BioTherapeutics		25,289			20,908
Corporate		28,937			53,469
Total	$	63,691		$	79,573

	As of		As of
	March 31,		December 31,
	2020		2019
Identifiable Assets
Public Health Solutions	$	813,121	$	1,018,673
Specialized BioTherapeutics		64,351		41,705
Corporate	$	8,970,202	$	6,714,982
Total	$	9,847,674	$	7,775,360